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PathogenicityThe direct transmission of highly pathogenic avian inﬂuenza (HPAI) viruses to humans in Eurasia and
subsequent disease has sparked research efforts leading to better understanding of HPAI virus transmission
and pathogenicity in mammals. There has been minimal focus on examining the capacity of circulating low
pathogenic wild bird avian inﬂuenza viruses to infect mammals. We have utilized a mouse model for
inﬂuenza virus infection to examine 28 North American wild bird avian inﬂuenza virus isolates that include
the hemagglutinin subtypes H2, H3, H4, H6, H7, and H11. We demonstrate that many wild bird avian
inﬂuenza viruses of several different hemagglutinin types replicate in this mouse model without adaptation
and induce histopathologic lesions similar to other inﬂuenza virus infections but cause minimal morbidity.
These ﬁndings demonstrate the potential of wild avian inﬂuenza viruses to directly infect mice without prior
adaptation and support their potential role in emergence of pandemic inﬂuenza.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The 1997 outbreak of highly pathogenic H5N1 avian inﬂuenza
(HPAI) virus in humansmarked the beginning of intense investigation
into the pathogenesis of human infections with avian inﬂuenza
viruses (AIV) (Subbarao et al., 1998). These “novel” AIVs are of
concern not only because of the severity of disease observed but also
because they have a pandemic potential (Li et al., 2004; Maines et al.,
2005). Since the 1997 H5N1 outbreak, many other examples of human
infections with AIVs have occurred. These outbreaks have also
demonstrated that other hemagglutinin subtypes of AIVs are capable
of direct human infection, such as H7 and H9, with varying morbidity
and mortality (Belser et al., 2009; Butt et al., 2005; Fouchier et al.,
2004; Guo, Li, and Cheng, 1999; Koopmans et al., 2004). In cases of
H5N1 infections, disease in humans has been geographically and
temporally associated with a HPAI outbreak in poultry (Beigel et al.,
2005). Human infections with H7 and H9 AIV subtypes have also most
frequently been attributed to transmission from poultry (Belser et al.,
2009; Butt et al., 2005). The mechanism of how AIVs are capable of
directly infecting humans and other mammals is multifactorial,
including differences in hemagglutinin receptor speciﬁcity and
polymerase activity, and is still being elucidated (Gabriel et al.,
2007; Gambaryan et al., 2006; Labadie et al., 2007; Li et al., 2005;
Rogers and Paulson, 1983; Thompson et al., 2006; van Riel et al.,2007). These studies have primarily focused on H5N1 virus isolates,
and there is minimal information available on the abundant other
AIVs that exist in nature.
Direct transmission of AIV from birds is not unique to humans but
also observed in other mammals not traditionally considered
susceptible to inﬂuenza, such as domestic cats and dogs, wild cats,
and seals (Geraci et al., 1982; Hinshaw et al., 1984; Keawcharoen
et al., 2004; Klingeborn et al., 1985; Klopﬂeisch et al., 2007; Song et al.,
2008; Songserm et al., 2006a, 2006b). Again, a range of avian inﬂuenza
hemagglutinin subtypes have been demonstrated to infect other
mammals, including H4, H5, H6, H7, H9 and H10, by natural or
experimental infection. Investigators are ﬁnding increasingly more
avian inﬂuenza subtypes that can productively infect mammals
resulting in varied morbidity (Belser et al., 2007; Dybing et al.,
2000; Gillim-Ross et al., 2008; Hinshaw et al., 1981; Joseph et al.,
2007; Rigoni et al., 2007; Wan et al., 2008). The mouse model for
inﬂuenza infection has been widely used in studies of human and
avian inﬂuenza to elucidate virulence and pathogenesis of these
viruses (Fislova et al., 2009; Lu et al., 1999; Tumpey et al., 2007;Ward,
1997). Pathogenicity studies have primarily focused on HPAI isolates
that have been involved in human infections, with only a small
number of studies examining low pathogenic avian inﬂuenza (LPAI)
isolates from poultry and even fewer isolates examined from wild
birds (Gillim-Ross et al., 2008; Henzler et al., 2003; Joseph et al., 2007;
Wan et al., 2008). Wild birds are the reservoirs for all inﬂuenza
subtypes and recently have been implicated in the spread of HPAI
H5N1 (Cattoli and Capua, 2007; Keawcharoen et al., 2008; Li et al.,
2004; Olsen et al., 2006; Stallknecht and Brown, 2007). Examining the
Fig. 1. Wild aquatic bird inﬂuenza virus isolates replicate to high titer in mice without
adaptation. Groups of two bars represent a single isolate that replicated efﬁciently in
mice (from Table 1) inoculated i.n. at two dilutions (1:10 and 1:100) with lung
collected and titrated at day 4 p.i. in MDCK cells. The concentration of the inoculum for
the 1:10 dilution is listed after the isolate name (expressed in PFU/mouse). Each bar
represents the average lung titer for a group of four mice. The dashed line is the limit of
detection (2.4 log10TCID50/g).
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mouse model is a step towards deeper understanding of the risks and
mechanisms of avian inﬂuenza infections in mammals.
All pandemic inﬂuenza viruses since 1918, including the 2009
H1N1 virus have at least an AIV component (Glaser et al., 2005;
Matrosovich et al., 2000; Stevens et al., 2006). There is a possibility
that the next pandemic inﬂuenza precursor is circulating in the wild
bird population. In this study, the mouse model is utilized for
inﬂuenza to examine a large variety of AIVs isolated from wild birds
from inﬂuenza surveillance in the United States. Results demonstrate
that many of these isolates can replicate in the lung of mice and
induce pulmonary lesions with minimal morbidity. For some isolates,
virus was localized with immunohistochemistry and demonstrated
robust replication in respiratory epithelial tissues. Serology after
infection showed that immunogenicity was variable and unrelated to
replication or pathology. These data support the idea that humans and
other mammals may be directly infected with wild bird AIVs, in some
cases subclinically and without seroconversion, providing a potential
avenue for emergence of inﬂuenza viruses with pandemic potential
via mutation and/or reassortment.
Results
Wild bird avian inﬂuenza viruses replicate robustly in mice
As a primary in vitro screen, more than 400 wild bird avian
inﬂuenza virus isolates were screened for replication inMDCK cells by
plaque assay. As plaquing in cell culture in the absence of exogenous
trypsin has been shown to indicate the potential for increased
pathogenicity for avian inﬂuenza viruses (Rimmelzwaan et al., 2006;
Zitzow et al., 2002) and the 1918 inﬂuenza virus was shown to plaque
to a high titer in culture without addition of trypsin (Tumpey et al.,
2005), wild bird isolates were tested for replication in MDCK cells in
the presence and absence of trypsin. While this phenotype is not
associated with infectivity in mice, it provided ameasure of infectivity
in a mammalian culture system and a means to select for potentially
pathogenic viruses. TheMDCK plaque assay identiﬁed 114 viruses that
replicated to high titer inMDCK cells andmost isolates lost less than 20
fold of the titer the absence of exogenous trypsin (data not shown).
Twenty-eight of these viruses were selected for in vivo screening.
Wild bird isolates selected for in vivo replication analysis covered
six hemagglutinin (HA) subtypes and four known avian species
(Table 1). Replication of each isolate in mice was categorized as: “No
replication” (no virus was detected by TCID50 assay from lung
samples), “poor replication” (virus detected from lung samples was
low titer and/or only present in mice inoculated with a high
concentration inoculum), and “efﬁcient replication” (virus detected
from lung samples was high titer and present in mice inoculated with
both concentrations of virus). Many of the isolates (71%) were able to
replicate in the mouse lung when assessed on day 4 post-inoculation
(p.i.) by TCID50 assay, where 29% of these isolates showed efﬁcient
replication (Table 1). Lung titers in individual mice from isolates that
demonstrated efﬁcient replication are shown in Fig. 1. Inoculum
concentration was not standardized as viruses only grew to a
moderate titer and repeated passage of virus in embryonated chicken
eggs (ECE) to derive a high-titer stock was speciﬁcally avoided.
Despite this lack of standardization, the wide range of inoculum
concentrations (as low as 5.5E+02 PFU/mouse and as high as 3.5E+
05 PFU/mouse) between isolates that had efﬁcient replication in the
mouse lung did not appear to be associated with the magnitude of
TCID50 virus titer from the lung on day 4 p.i. (Fig. 1). Virus was not
detected in mock infected mice via TCID50 assay.
Three virus isolates that exhibited efﬁcient replication in the
mouse lung were further selected for detailed pathogenesis studies
(viruses RT/645, RT/625, and RK/470). These particular isolates were
selected to diversify the HA subtypes examined. A 50% mouseinfectious dose (MID50) was elucidated for each of these three
selected isolates. The MID50 was similar for RT/645 (2.5E+03 PFU/
mouse) and RT/625 (1.2E+03 PFU/mouse) but much lower for RK/
470 (3.0E+01 PFU/mouse).
Wild bird avian inﬂuenza virus infection exhibits low pathogenicity in
mice despite robust replication in mouse lung
Clinical signs in mice inoculated with 20MID50 of RT/645, RT/625,
or RK/470 were mild and included slightly rufﬂed fur on days 1 and 3
post-inoculation. Similar clinical signs were observed on day 1 p.i. in
mock infected mice; these clinical signs were attributed to anesthetic
recovery. Clinical signs in X31 inoculated mice included rufﬂed fur
and lethargy on days 3 and 5 post-inoculation. Mice infected with RT/
645 and RK/470 exhibited more weight loss than mice infected with
RT/625 and mock infected control mice on day 2 p.i. and weight gain
remained poor in mice infected with RK/470 on day 3 p.i. (Fig. 2).
Despite these differences, mice infected with RT/625, RT/645 and RK/
470 exhibited overall minimal weight loss early p.i. that was not
signiﬁcantly different from mock infected control mice by a Student's
t test. In comparison, mice infected intranasally with X31 and
monitored for weight loss for other studies in our laboratory exhibit
approximately 15–20% peak weight loss on day 5 post-inoculation.
One PBS inoculatedmousewas found to be an outlier by Dixon'sQ test
based on weight loss data and dropped from the group.
Virus replication in the mouse lung was further examined over time
by infectingmicewith 20MID50 of each of the selected isolates (RT/645,
RT/625, and RK/470) and euthanizing mice to determine virus titer in
the lung at multiple time points (Fig. 3). All viruses reached a similar
peak titer in mouse lungs (2.4E +07 to 7.7E+07 TCID50/g). Mice
infectedwith RT/625 andRK/470 bothhad a pattern of peak virus in the
lung at day 5 p.i. but RT/645 had a less clear time point of peak virus,
with highest titers around days 1 and 3 post-inoculation. Virus was
present inmouse lung up to day 7 p.i. for all three viruses and cleared by
day 14 p.i.
The spleen, liver, and kidney of mice infected with RT/625 and RT/
645 (day 5 p.i.) and the brain of mice infected with RT/625 (day 5 p.i.)
Fig. 2. Weight loss in mice infected with selected wild aquatic bird inﬂuenza virus
isolates. Groups of ﬁve mice were inoculated with 20MID50 of RT/625 (H6N4), RT/645
(H2N9), RK/470 (H7N3), or mock-infected with PBS only. Weights were tracked daily
and percent weight lost compared to starting weight calculated. Daily weight loss was
not statistically signiﬁcant by Student's t test between virus inoculated mice and mock
infected mice.
Fig. 3. Kinetics of viral infection of RT/625, RT/645, and RK/470 in the lung of infected
mice. Each bar represents the viral titer in the lung of an individual mouse infected with
20MID50 of virus for viruses RT/625 (H6N4), RT/645 (H2N9), and RK/470 (H7N3). The
dashed line is the limit of detection (2.4 log10TCID50/g).
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subset of mice from both RT/625 and RT/645 had evidence of low
titers of virus in the spleen and liver and these samples were further
evaluated via virus isolation in ECE. Virus isolation in eggs indicated
that a single mouse infected with RT/645 had inﬂuenza virus present
in the liver, which was conﬁrmed by real-time PCR for inﬂuenza (data
not shown).
Wild bird avian inﬂuenza virus infection induces pulmonary lesions
in mice
The lungs of mice infected with RT/645, RT/625, and RK/470
exhibited similar histopathologic lesions aswell as a similar resolution
of lesions; however, development of lesions differed with RT/625
lagging slightly behind RT/645 and RK/470. No signiﬁcant histopath-
ologic lesions were present in RT/645, RT/625, or RK/470 infected
mice day 1 post-inoculation. By day 3 p.i., mice infected with RT/645
and RK/470 had a necrotizing bronchiolitis in many bronchioles and
peribronchiolar inﬂammation, but mice infected with RT/625 exhib-
ited only rare scattered areas of peribronchiolar inﬂammation (Fig. 4).
A similar average percentage of lung was affected by inﬂammation on
day 3 p.i. for all viruses (1.5% for RT/625, 2.7% for RT/645, and 2.0% for
RK/470). Peribronchiolar inﬂammation present in mice infected with
RT/625 at day 3 p.i. was primarily lymphocytes, with fewer macro-
phages and neutrophils present in adjacent alveoli, where in RT/645
and RK/470 infected mice the composition of inﬂammatory cells was
more neutrophilic. Mild tracheal inﬂammation, characterized by small
numbers of lymphocytes within the tracheal submucosa, was present
in some RT/625 and RK/470 infected mice. Many apoptotic tracheal
epithelial cells were observed only in RK/470 infected mice at day 3
post-inoculation. In X31 infectedmice on day 3 p.i., therewas a striking
necrotizing bronchitis and bronchiolitis with loss of epithelium and
peribronchiolar cell debris with some inﬂammatory cells.
Histopathology in mice on day 5 p.i. again showed that lesions in
mice infected with RT/645 and RK/470 were ahead of mice infected
with RT/625. Mice infected with RT/645 and RK/470 had continued
peribronchiolar pneumonia and necrotizing bronchiolitis; however,
the necrotizing bronchiolitis was resolving by this point in time and
the bronchiolar epithelium was beginning to become hyperplastic
(Fig. 4). Conversely, mice infected with RT/625 had continued
peribronchiolar pneumonia that increased in severity and also a
necrotizing bronchitis and bronchiolitis appeared at this time point.Mice infected with RT/625 exhibited prominent lymphocytic peri-
vascular cufﬁng. The degree of inﬂammation present in the lung was
slightly higher on day 5 p.i. compared to day 3 p.i., but similar
between all viruses examined (8.6% for RT/625, 5.7% for RT/645, and
3.5% for RK/470). No lesions were present in the lungs of mock
infectedmice (Fig. 4). Mice infectedwith X31 had continued lesions of
necrotizing bronchitis and bronchiolitis with peribronchiolar
Fig. 4. Histopathology in lung of AIV infected mice on days 3 through 28 post-inoculation (p.i.). Mice infected with RT/625 (H6N4), RT/645 (H2N9), or RK/470 (H7N3) have
bronchiolar necrosis (arrow) and peribronchiolar inﬂammation (asterisk). Inﬂammation was most severe in RT/625 (H6N4) infected mice on day 7 post-inoculation.
Peribronchiolar inﬂammation was resolving as dense nodular collections of lymphocytes on days 14 and 28 post-inoculation. Positive control infected mice (X31 day 3 p.i.) have
similar bronchiolar necrosis as AIV inoculated mice. Mock infected mice have no lesions on histopathology.
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were hyperplastic at this time point.
Mice infected with RT/625 had continued peribronchiolar pneu-
monia and necrotizing bronchiolitis at day 7 p.i.; however, the
pneumonia was more widespread (Fig. 4). Mice infected with RT/645
and RK/470 had similar peribronchiolar pneumonia day 7 p.i. as
described for day 5 p.i.; however, the degree of inﬂammation was
much less in severity than RT/625 (24.9% lung affected for RT/625,
3.6% for RT/645, and 5.6% for RK/470) and there was complete
resolution of bronchiolar necrosis. Additionally, there was prominent
type II pneumocyte hyperplasia observed in some mice infected with
RT/645 beginning at day 7 postinoculation.
Examination of lungs in infected mice on days 14 and 28 p.i.
revealed similar resolution of mice infected with RT/625, RT/645, and
RK/470. Peribronchiolar inﬂammation in all of these mice was
primarily consolidated areas of lymphocytes and there were many
peribronchiolar areas of type II pneumocyte hyperplasia. Lesions
progressed to scattered nodular collections of peribronchiolar
lymphocytes by day 28 p.i. in all virus infected mice. Mice infected
with X31 had similar histopathologic changes of lymphocytic
inﬂammation and type II pnuemocyte hyperplasia on day 14 as the
three AIVs that were examined.
Immunohistochemistry (IHC) for the nucleoprotein of inﬂuenza A
on the lungs of mice infected with RT/625, RT/645, and RK/470 allexhibited strong positive intranuclear staining of tracheal, bronchio-
lar, and/or alveolar epithelium in areas of histopathologic lesions
between days 3 and 5 p.i. (Fig. 5). Mice infected with RT/625 had very
minimal positive staining on day 3 p.i. but staining became more
prominent by day 5 p.i., versus RT/645 and RK/470, which both had
more prominent positive staining on day 3 p.i. and magnitude of
positive staining was lessened by day 5 post-inoculation. These
observations are in concord with histopathology that indicates earlier
productive infection in mice infected with RT/645 and RK/470 versus
mice infected with RT/625. Additionally, no positive staining of
tracheal epithelium was observed in mice infected with RT/625, but
there was good staining of the tracheal epithelium on day 3 p.i. for
mice infectedwith RT/645 and RK/470. Therewas no positive staining
in the lung of mock infectedmice examined on day 5 post-inoculation.
Mice infected with RT/625 and RT/645 did not have any
histopathologic lesions in the nasal turbinates at any time point
(days 1, 3, 5, 7, and 14 p.i.). Two mice that were infected with RK/470
(day 5 p.i.) and one mouse that was infected with RK/470 (day 7 p.i.)
had a single area in the nasal cavity that contained mixed mucus and
neutrophils, but there were no lesions in the nasal epithelium in any
of the RK/470 infected mice. Although epithelial lesions were not
observed, there was positive intranuclear staining in very rare ciliated
epithelial cells of the paranasal sinuses in mice infected with RT/645
and in mice infected with RK/470. There was no positive staining for
Fig. 5. Viral antigen in the lung and nasal turbinates of AIV infected mice on days 3 and 5 post-inoculation. By immunohistochemistry, mice infected with RT/625 (H6N4), RT/645
(H2N9), or RK/470 (H7N3) have strong positive intranuclear staining for the nucleoprotein of inﬂuenza A in tracheal epithelium (RK/470 day 3 p.i.) , bronchiolar epithelium (RT/
645 day 3 p.i.), and alveolar epithelium (RT/625 day 5 p.i.) for all three AIV isolates in infected mice. There is also strong positive intranuclear staining of the nasal turbinate
epithelium (RT/645 NT day 3 p.i.) in some AIV infectedmice. Mock infected mice have no staining for viral antigen (Allantoic ﬂuid day 5 p.i.). Positive control infected mice (X31 day
3 p.i.) have similar strong positive intranuclear staining of bronchiolar epithelium as AIV inoculated mice. Cellular necrosis is evident by luminal debris in the airways (arrow).
Fig. 6. Serum antibody response in mice after wild AIV infection. Groups of 5 mice were
inoculated with 20MID50 of RT/625 (H6N4), RT/645 (H2N9), or RK/470 (H7N3) and
sera were collected day 23 post-inoculation. Sera from individual mice were tested
against whole virus and allantoic ﬂuid, and the difference was averaged and plotted.
Sera from PBS inoculated mice were tested against allantoic ﬂuid.
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viruses.
There was only a single extrapulmonary lesion observed in mice
infected with the three AIVs, this was thymic atrophy with lymphocyte
depletion present in a mouse infected with RT/645 on day 3 post-
inoculation. Thymic atrophy has been associated with inﬂuenza
infection in mice; however, we did not consistently observe this lesion
in mice infected with this virus and observation of thymic atrophy in a
different study occurredmuch later in infection (Fislova et al., 2009). No
other lesions were observed in any of the organs examined for mice
infected with RT/625, RT/645 or RK/470 on days 1, 3, 5, 7, or 14 p.i.
Wild bird avian inﬂuenza viruses exhibit differences in immunogenicity
in mice
A serum ELISAwas performed on sera collected frommice infected
with RT/625, RT/645, or RK/470 on day 23 p.i. to assess seroconver-
sion after AIV infection. All ﬁve mice infected with RT/645 or RK/470
had a robust IgG response to the speciﬁc AIV with a prominent signal
from serum dilutions up to 1:320 (Fig. 6). In contrast, mice infected
with RT/625 had a poor IgG response to the viral infection, with little
difference in signal from serum dilutions when compared to mock
infected mice (Fig. 6).
285E.A. Driskell et al. / Virology 399 (2010) 280–289Discussion
The perspectives regarding the host range and mechanisms of
inﬂuenza infections are ever broadening to a view of a more
promiscuous virus than previously thought. Through natural and
experimental infections, the list of mammals that are susceptible to
AIV infection is rapidly increasing along with the scope of organ
tropism of these viruses. These ﬁndings apply not only to highly
pathogenic AIVs, but also to low pathogenic viruses from poultry
(Belser et al., 2007; Gillim-Ross et al., 2008; Joseph et al., 2007; Wan
et al., 2008). These evolving viewpoints are further supported with
these data that includes a large scope of avian inﬂuenza isolates from
wild birds, demonstrating that many AIVs from wild birds can
replicate in the BALB/c mouse model without adaptation and that
hemagglutinin subtype was not a barrier to infection (Table 1).
Methodology in screening the isolates for replication in the mouse
lung was limited by the titer of the virus stock, as the virus isolates
were minimally passaged to avoid mutations associated with egg
adaptation. For the purpose of these studies it was critical to keep
these isolates as close as possible to the original sample from the wild
bird, to better assess replication of the original isolate. This resulted in
many isolates that were only of moderate titer. The inoculum
concentration for the primary screening experiment could not be
standardized, as lowering the inoculum concentration for some
isolates to normalize the concentration could have resulted in missing
some isolates that were able to replicate. This method enabled
identiﬁcation of the maximum number of isolates that replicated in
themice and did not have any effect on peak viral titer for isolates that
exhibited efﬁcient replication (Fig. 2), although some concentration
effect was observed on isolates that exhibited poor replication (data
not shown).
Mice did not require a high concentration inoculum for infection
with RT/625, RT/645, or RK/470, as evident in the MID50 for each
virus. Studies with LPAI H7 viruses have also shown that low
concentrations of virus are adequate for infection of mice (Belser
et al., 2007). RK/470 had a very low MID50 in mice, however, when
mice were inoculated with 20MID50 for pathogenicity studies; several
mice did not become infected. Therefore, it is possible that a higher
concentration of inoculum was required for consistent infection of all
these mice. Despite these observations, it is also interesting to note
that all H7 subtype viruses examined in this screen replicated to a
high titer despite a low inoculum concentration, suggesting there is a
lower threshold for infection in the H7 subtypes (Fig. 1). Additionally,
although there was not an equal number of hemagglutinin subtypes
represented, all viruses of the H7 subtype exhibited efﬁcient
replication compared to other subtypes that exhibited varied ability
to replicate inmouse lung (Table 1). The H7 subtype of avian inﬂuenza
is of particular concern in human infections (Belser et al., 2009;
Gillim-Ross and Subbarao, 2006). The data shown here is suggestive of
an increased ability of the H7 viruses to replicate in the mouse model
and further investigation to examine more isolates of this subtype
may provide insight to mechanisms of mammalian infection. While
previous studies focused on LPAI and HPAI H7 inﬂuenza viruses
isolated from humans and poultry, the viruses tested here were
exclusively isolates from North American waterfowl and shore birds.
This presents additional opportunities for transmission; whether
through contact with infected wild birds or environmental exposure
in the birds' habitats (Rohani et al., 2009).
Infections in these mice were very similar to infections with
human or other LPAIVs in BALB/c mice regarding pathogenesis and
lesion development (Buchweitz, Karmaus, and Harkema, 2007). Peak
viral titers in the lung for other LPAIVs are generally at day 4 but can
occur as early as day 2 with virus present in the lung through day 7
(Gillim-Ross et al., 2008; Joseph et al., 2007). In this study, there is a
similar peak of infection based on virus titers from the lung as RT/625
and RT/470 had peak titers in most mice on day 5 p.i. and RT/645 hadpeak titers in most mice at days 1 and 3 p.i. (Fig. 3). Previous
immunohistochemistry studies on inﬂuenza infected mice also
demonstrate similar strong intranuclear staining of bronchiolar
epithelium (Fislova et al., 2009; Rigoni et al., 2007). Interestingly, all
of the viruses we examined demonstrated positive viral antigen
staining of not only bronchiolar epithelial cells but also alveolar
epithelial cells, but in the X31 infected mice viral antigen staining was
restricted to bronchiolar epithelium. Similar ﬁndings were present in
a study of mouse adapted inﬂuenza viruses, where IHC staining for
inﬂuenza was only observed in bronchiolar epithelial cells (Fislova
et al., 2009). Moreover, there was prominent type II pneumocyte
hyperplasia present in mice infected with viruses RT/625, RT/645,
and RK/470 by day 14 p.i., also supporting that there was signiﬁcant
alveolar epithelial damage. HA receptor speciﬁcity is thought to be a
large contributor to host range, as avian inﬂuenza strains preferen-
tially bind to cell glycoproteins/glycolipids that have terminal sialyl-
galactosyl (SA) residues with a 2–3 linkage [Neu5Ac(α2-3)Gal] and
human inﬂuenza strains preferentially bind to terminal 2–6 linked
glycoproteins/glycolipids [Neu5Ac(α2-6)Gal] (Connor et al., 1994;
Mansﬁeld, 2007). Additionally, the distribution of these receptors on
cells of the respiratory tract is demonstrated to vary between
mammalian species and mice have been shown to have primarily
the 2–3 linked SA receptor in ciliated epithelial cells in large airways
and in type II pneumocytes (Ibricevic et al., 2006; van Riel et al., 2007).
Indeed, many studies of HPAI H5N1 have demonstrated enhanced
alveolar damage in humans andmice, suggesting increased afﬁnity for
binding of these cells compared to human strains of inﬂuenza (Abdel-
Ghafar et al., 2008; Dybing et al., 2000). This afﬁnity for binding cells
of the lower respiratory tract was also demonstrated with some LPAI
isolates (van Riel et al., 2007). Our results are also supportive that
these wild bird AIVs have an increased binding afﬁnity for receptors
present on alveolar epithelial cells compared to human strains. In
mice infected with RT/645 and RK/470 there was minimal presence
of viral antigen in the nasal cavity via IHC with no antigen present in
RT/625. Other inﬂuenza isolates, particularly human origin, typically
exhibit replication in this area of the upper respiratory tract. The
minimal presence of antigen in the nasal turbinates despite efﬁcient
replication and lesions in the lung supports that these isolates, similar
to other avian isolates, have a preference for replication in the lower
respiratory tract. There is recent evidence that the regional replication
preferences of avian inﬂuenza in mammals are in part due to
mutations in PB2 that change temperature and cell type replication
preferences in the virus (Hatta et al., 2007). Further investigation into
the molecular aspects of these wild type avian viruses may provide
insight into common molecular mechanisms of host range and
pathogenicity in mammals.
It has been shown that many HPAI viruses have extrapulmonary
spread, with virus presence and lesions most frequently in the brain
and spleen of infected mice (Belser et al., 2007; Joseph et al., 2007;
Maines et al., 2005; Rigoni et al., 2007). Examination of LPAIVs has
demonstrated that some of these viruses that exhibit pulmonary
replication also have the capacity for extrapulmonary spread, while
others do not (Gillim-Ross et al., 2008; Joseph et al., 2007).
Interestingly, mouse adapted inﬂuenza viruses have also been
shown to have extrapulmonary spread to numerous organs with
possible viremia, regardless of virulence (Fislova et al., 2009).
Additionally, a case study of a human infection with HPAI H5N1
demonstrated viral antigen in extrapulmonary sites without lesions in
these sites (Zhang et al., 2009). We also have evidence of inconsistent
extrapulmonary spread of one of the viruses examined (RT/645)
without signiﬁcant morbidity or extrapulmonary lesions in these
mice. This may be further supportive evidence that viremia and
extrapulmonary spread is not as uncommon as previously believed
and conclusions of virulence of an inﬂuenza isolate must be evaluated
not only in context of viral presence, but also with consideration of
morbidity and severity of lesions in the mouse model.
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very similar peak titers of virus, pulmonary lesions, and location of
viral antigen. However, slight differences were present between these
viruses, most notably in RT/625. This isolate exhibited slower
progression of viral infection, characterized by a later peak of
pulmonary lesions and viral antigen compared to RT/645 and RK/
470 (Fig. 4). Additionally, the amount of peribronchiolar inﬂamma-
tion in RT/625 was greater in magnitude than RT/645 and RK/470 on
day 5 post-inoculation. Viral titer in the lungs corresponded with the
progression of lesions in RT/625 (peak virus at day 5) and RT/645
(peak virus at days 1 and 3) but not as well with RK/470 (apparent
peak virus at day 5) regardless of inclusion or exclusion of the several
mice of RK/470 that did not become infected (Fig. 3). Interestingly,
there was a good antibody response in mice infected with RT/645 and
RK/470 but a poor response inmice infected with RT/625. In addition,
RT/625 infection caused marked lymphocytic inﬁltrates early in the
lung, whereas RT/645 and RK/470 infection resulted in primarily
neutrophilic inﬁltrates and followed a more typical inﬂammatory
pattern (Buchweitz, Karmaus, and Harkema, 2007). It is possible that
the differences in inﬂammation with RT/625 infection may be related
to an altered immune response or poor speciﬁc immune response to
the virus. Virus was present in all RT/625 infected mice through day 7
p.i.; additional sampling days between day 7 and day 14 p.i., in
addition to analysis of the cytokine and chemokines expressed during
infection would be useful to determine if there was an altered
immune response inﬂuencing viral clearance from the lung and
seroconversion compared to RT/645 and RK/470 infected mice.
Many inbred mouse strains including BALB/c are more susceptible
to inﬂuenza infection because of defective alleles in the Mx1 gene
(Staeheli et al., 1988). Studies have shown that mice with a wild-type
Mx1 gene are resistant to infection with LPAI and have lower viral
replication with HPAI H5N1 infections than BALB/c mice (HenzlerTable 1
Study viruses and their ability to replicate in mouse lung.
Virusa Name in this study
A/Ruddy Turnstone/NJ/650624/02 RT/624
A/Sanderling/DE/650623/02 San/623
A/Ruddy Turnstone/DE/650621/02 RT/621
A/Ruddy Turnstone/NJ/650638/02 RT/638
A/Ruddy Turnstone/DE/650645/02c RT/645
A/Ruddy Turnstone/DE/650580/02 RT/580
A/Ruddy Turnstone/NJ/650627 RT/627
A/Mallard/MN/199105/99 Ma/105
A/Mallard/MN/355808/00 Ma/808
A/Ruddy Turnstone/NJ/1321394/05 RT/394
A/Ruddy Turnstone/NJ/1321398/05 RT/398
A/RuddyTurnstone/NJ/1321397/05 RT/397
A/RuddyTurnstone/NJ/1321396/05 RT/396
A/Ruddy Turnstone/NJ/1321395/05 RT/395
A/Mallard/MN/199084/99 Ma/084
A/Ruddy Turnstone/NJ/1321399/05 RT/399
A/Mallard/MN/355807/00 Ma/807
A/Ruddy Turnstone/DE/650625/02c RT/625
A/RuddyTurnstone/NJ/650677/02 RT/677
A/Sanderling/DE/650680/02 San/680
A/feces/DE/650574/02 Fe/574
A/Red Knot/NJ/1523470/06c RK/470
A/Sanderling/NJ/1523471/06 San/471
A/Ruddy Turnstone/1523477/06 RT/477
A/Ruddy Turnstone/NJ/650615/02 RT/615
A/Ruddy Turnstone/NJ/650626/02 RT/626
A/Mallard/MN/199116/99 Ma/116
A/feces/DE/650619/02 Fe/619
X31 X31
a Each of the 28 avian virus isolates listed were surveyed for ability to infect lungs of mice
b Isolates were scored as: “No” which represents absence of virus in infected mice lung f
infected mice lung only at the higher inoculum dilution and/or low titer virus at either inocu
in infected mice lung at both inoculum dilutions on TCID50 assay. The isolate X31 was used
c Indicates isolates that were selected for in depth pathogenicity studies.et al., 2003; Tumpey et al., 2007). Therefore, interpretation of the
potential of mammalian and human infection with these wild bird
AIVs must be carefully evaluated in additional models. Nonetheless,
the evaluation of these wild AIVs in the BALB/c mouse model are
invaluable for selection of isolates for additional molecular and in vivo
studies using other animal models. Many of the isolates in this study
should be further explored to better understand mechanisms of AIV
infection in mammals. From this study, we conclude that numerous
wild bird AIVs replicate without adaptation and to high titer in the
mouse model. While all viruses induced lung pathology, the extent,
type and time course varied. Moreover, virus titer and lung pathology
were not necessarily associated with seroconversion. Deductions
about the behavior of inﬂuenza in BALB/c mice and mammals in
general should not simply be based onmagnitude of replication of the
virus or seroconversion, but also correlated with clinical signs,
evidence of morbidity, and severity of lesions. Avian inﬂuenza viruses
from wild bird populations could be crossing species barriers and
causing sub-clinical disease with limited seroconversion; providing
unknown opportunities for mutation and emergence of novel
inﬂuenza viruses.
Methods
Viruses
Avian inﬂuenza viruses used were cloacal swab isolates from wild
birds in the United States acquired from Southeastern Cooperative
Wildlife Disease Study at the University of Georgia collected between
1998 and 2006. Viruses used in this study are shown in Table 1.
Isolates used for in vitro screening were isolated from cloacal swabs in
9-day-old ECE at 37 °C for 72 h and then minimally passaged (3 or
fewer passages) in ECEs. Approximately 400 inﬂuenza virus isolatesSubtype Replication in mouse lungb
H2N4 Poor
H2N4 Efﬁcient
H2N9 No
H2N9 Poor
H2N9 Efﬁcient
H2N9 Efﬁcient
H2N9 No
H3N4 Poor
H3N4/8 Poor
H3N6 No
H3N6 No
H3N6 Poor
H3N6 No
H3N8 Poor
H3N8 Poor
H3N9 No
H4N6 Poor
H6N4 Efﬁcient
H6N4 Efﬁcient
H6N4 Poor
H6N8 Poor
H7N3 Efﬁcient
H7N3 Efﬁcient
H7N3 Efﬁcient
H11N2 No
H11N9 No
H11N9 Poor
H11N9 Poor
H3N2 Efﬁcient
by infecting groups of three to four mice with two serial tenfold dilutions of the virus.
or either inoculum dilution on TCID50 assay, “Poor” which represents virus presence in
lum dilution on TCID50 assay, and “Efﬁcient”which represents high titer virus presence
as a positive control.
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Darby canine kidney (MDCK) cells without the addition of trypsin
were selected for additional in vivo selection in mice, as this
phenotype is suggestive of enhanced pathogenicity of inﬂuenza
viruses. The original low passage isolates, once selected by in vitro
screening methods, were grown once more in 9- to 10-day-old ECE to
generate a stock of the virus. Allantoic ﬂuid pooled from eggs was
frozen in aliquots at−80 °C. Virus stocks were plaqued onMDCK cells
with trypsin to elucidate a PFU/mL titer.
Mouse experiments
Female 6- to 8-week-old BALB/c mice (Harlan Laboratories,
Indianapolis, IN) were anesthetized with intraperitoneal injection of
2,2,2-tribromoethanol in tert-amyl alcohol and inoculated intranasal-
ly with 50 μL of diluted virus in sterile phosphate buffered saline
(PBS). A screen to determine the replication capacity of selected AIV
isolates in mice was performed by harvesting lungs of mice inoculated
with a 1:10 dilution of virus stock (3–4 mice per virus) or a 1:100
dilution of virus stock (3–4 mice per virus) on day 4 post-inoculation.
A group of mice was mock infected with PBS and another group was
infected with X31 to serve as controls. Mouse experiments were
performed in enhanced BSL2 facilities in HEPA ﬁltered isolators.
Studies were conducted under guidelines approved by the Animal
Care and Use Committee of the University of Georgia. Clariﬁed lung
homogenate and ﬁxed lung tissue from selected inﬂuenza inoculated
mice (RT/625) exhibiting histopathologic lesions were negative for
Mycoplasma pulmonis via PCR.
The MID50 was determined as previously described (Cottey, Rowe,
and Bender, 2001). Brieﬂy, mice were infected with 10-fold dilutions
of each virus. Five mice per group were euthanized on day 4 p.i. and
clariﬁed lung homogenate was serially titrated in MDCK cells to
determine the MID50 calculated by the method of Reed and Muench
(1938). The pathogenesis of RT/625, RT/645, and RK/470 was
determined by inoculation of groups of mice with 20MID50 of virus
and harvesting lungs on days 1, 3, 5, 7, and 14 p.i. and harvesting
spleen, liver, kidney and brain on day 5 p.i (5 mice per virus per day).
Tissues were homogenized in 1 mL PBS, clariﬁed by centrifugation,
and frozen at−80 °C for later titration. Clariﬁed lung homogenatewas
titrated in MDCK cells starting at a 1:10 dilution with a limit of
detection at 102.4 TCID50/gram. Clariﬁed organ homogenate (spleen,
liver, kidney, and brain) was initially titrated in MDCK cells starting at
a 1:10 dilution. Samples were further selected for virus isolation in 9-
to 10-day-old ECE. Real time RT-PCR was performed on hemagglu-
tination assay positive samples from virus isolation. Brieﬂy, viral RNA
was extracted from allantoic ﬂuid by using RNeasy mini kit (Qiagen,
Valencia, CA) and the Qiagen one-step RT-PCR kit was used for RRT-
PCR with a Stratagene MX300P/3005P thermocyler and Mx Pro QPCR
software (La Jolla, CA). Reaction mixture and PCR cycling protocol is
available upon request. An inﬂuenza virus matrix gene speciﬁc primer
and probe set were used as follows: primerM+25, sequence AGA TGA
GTC TTC TAA CCG AGG TCG; primer M-124, sequence TGC AAA AAC
ATC TTC AAG TCT CTG; and probeM+64, sequence FAM-TCA GGC CCC
CTC AAA GCC GA-TAMRA (Biosearch Technologies, Novato, CA).
For morbidity and seroconversion studies, ﬁve mice per group for
viruses RT/625, RT/645, RK/470, and a mock infected PBS group were
inoculated with 20MID50 of virus and weighed daily for 11 days and
then every other day for an additional 4 days. Serum was collected
from thesemice on day 23 p.i. to assay serum antibody response to the
AIVs. Statistical signiﬁcance of weight loss between groups of mice
was determined using Student's t test.
Histopathology and immunohistochemistry
Tissues from infected and control mice were examined by
histopathology and immunohistochemistry. Mice were inoculatedwith 20MID50 virus and lung, trachea, thymus, thyroid, esophagus,
heart, spleen, liver, stomach, intestine, pancreas, kidneys, adrenal
gland, ovary, uterus, bladder, brain, and nasal turbinates were
collected on days 1, 3, 5, 7, 14, and 28 p.i. (three mice per virus per
day). The lungs were inﬂated with 10% neutral buffered formalin and
all tissues were preserved in 10% neutral buffered formalin. Additional
groups of mice were inoculated with allantoic ﬂuid in sterile PBS (3
mice) or with X31 (9 mice) to serve as controls and organs were
collected on day 5 p.i (PBS) or days 3, 5, and 14 p.i. (X31). Five equal
transverse sections were made through the entire lungs. Mouse skulls
were decalciﬁed and four transverse sections were made through the
nasal cavity to examine the nasal turbinates. Tissues were routinely
processed, embedded and stained with hematoxylin and eosin. The
severity of inﬂammation in lungs of infected mice was calculated by
ﬁnding the average percent area of lung affected by inﬂammation per
day p.i. for each virus using Image Pro Plus software vs. 4.5.1
(MediaCybernetics, Bethesda, MD).
Immunohistochemical staining was performed on lung tissue
(days 1, 3, 5, and 7 p.i. for 3 mice per day) or on nasal turbinates (days
3 and 5 p.i. for 2 mice per day) and all other organs (day 5 p.i. for 2
mice per day) in mice infected with RT/625, RT/645, and RK/470.
Immunohistochemistry on mouse lung tissue was performed using a
commercially available mouse monoclonal antibody to the nucleo-
protein of inﬂuenza A virus at a 1:200 dilution (Biodesign Inter-
national, Sako, Maine) or on mouse nasal turbinates and organs other
than lung using a commercially available goat polyclonal antibody to
the nucleoprotein of inﬂuenza A virus at a 1:10,000 dilution (Bio-
design International, Sako, Maine), as excessive background staining
was observed in nasal turbinates and organs using the mouse
monoclonal. Tissues were deparafﬁnized and blocked with a com-
mercial protein blocking agent (Dako Cytomation, Carpinteria, CA)
and a linked strepavidin-biotin immunoperoxidase system was used
for immunolabeling. The reaction was visualized with 3,3′-diamino-
benzidine substrate (Dako Cytomation, Carpinteria, CA).
Serum ELISA assay
Sera from individual mice were assayed via ELISA against each
whole inﬂuenza virus (RT/625, RT/645, or RK/470) inoculated in the
individual mouse. Additionally, the same sera were assayed against
allantoic ﬂuid to account for any antibodies generated against
components other than the virus. Virus or allantoic ﬂuid was coated
100 μL per well on 96 well Immulon 2HB microtiter plates and
incubated 24 h at 4 °C. Two-fold dilutions of sera were applied to
pre-absorbed plates, starting with a dilution of 1:20 and virus
speciﬁc antibodies were measured using alkaline phosphatase
labeled goat anti mouse IgG(H+L) (Kirkegaard and Perry Laborato-
ries, Gaithersburg, MD). The p-nitrophenyl phosphate substrate
(Kiregaard and Perry Laboratories, Gaithersburg, MD) was added and
absorbance measured at 405 nm on a 96-well format plate reader
(BioTek, Winooski, VT ). Absorbance readings for sera against
allantoic ﬂuid were subtracted from absorbance readings for sera
against virus and plotted.
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